Increasing DR Screening Through TOP: Supporting Implementation and Identifying Opportunities for Scale up in Ontario
NCT ID: NCT03927859
Last Updated: 2019-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
420 participants
INTERVENTIONAL
2018-07-05
2019-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Project Open - Use of Administrative Health Data to Increase Diabetic Retinopathy Screening
NCT05074342
Diabetic Retinopathy and Subclinical Signs of Disease Transition
NCT03635671
Automated Diagnostic Test for Diabetic Retinopathy in Brazilian Mass Screening
NCT02927561
Assess Screening for Diabetic Retinopathy Using Retinal Camera in Family Medicine Clinic
NCT03828890
Smartphone Screening for Eye Diseases
NCT03076697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is, therefore, important to identify which intervention strategies, or combination of strategies, will be most effective in improving screening rates in Ontario. While many studies have examined the effects of various strategies individually, for this project we aim to use several interventions that have been identified in the past as being effective and examine the effects of these interventions alone or in combination.
The approach we are taking in this study is the Multiphase Optimization Strategy (MOST). This study design approach consists of three stages: a screening phase, a refining phase and a confirming phase.
During the screening phase, several intervention approaches are evaluated alone or in combination with each other in order to assess which intervention(s) have the greatest potential for impact on the selected outcome. During the refining phase of MOST, the selected components are fine-tuned and issues such as optimal levels of each component are investigated. During the confirming phase, the selected components are delivered at optimal levels and the intervention showing greatest promise is evaluated through a standard randomized controlled trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mailing Letter
Patients assigned to this arm, in which a letter is mailed out will receive 2 pamphlets in the mail. One pamphlet described the teleophthalmology program and the other pamphlet was designed by the Canadian Association of Ophthalmologists and describes what DR is and why screening is important. The letter will also contain contact information about the closest TOP to the area of the PCP practice.
a mail letter, a phone call and a phone call plus mailed letter
All patients will be administered an intervention that will contain one or more of 3 possible interventions (a mail letter, a phone call and a mail plus phone call). Some patients will also be assigned into a condition where none of the interventions will be present.
Patients at Black Creek CHC will only be offered a phone or a phone plus incentive intervention or a no intervention.
Phone call
Administrative staff on site of each practice will contact all patients assigned to this arm by a phone call.
The patient will be informed that they are calling from the family health practice that the patient belongs to. The reason for the call will be that the patient has been identified as somebody who is likely overdue for a screening test. Patients will be asked if they have had a screening test done recently, and if not, they will be offered an appointment. Patients that refuse an appointment, will be politely probed for reasons and attempts will be made to provide them with information on potential solutions to these barriers (e.g. patients working 9-5 on weekdays will be informed that they can access TOP on evenings). The call will also be used as an opportunity to inform patients about the importance of screening.Three attempts will be made to reach each patient. Only a single voicemail message will be left, when the possibility is available.
a mail letter, a phone call and a phone call plus mailed letter
All patients will be administered an intervention that will contain one or more of 3 possible interventions (a mail letter, a phone call and a mail plus phone call). Some patients will also be assigned into a condition where none of the interventions will be present.
Patients at Black Creek CHC will only be offered a phone or a phone plus incentive intervention or a no intervention.
Mail + Phone call
Patients assigned to this arm will first have letters mailed out to them (identical to the ones mailed out in the letter only arm). A week later, the letter will be followed up by a phone call as per the phone only arm. Patients will be asked if they have already booked, and if not, will be provided with information about the program as per the phone call script in the phone only arm.
a mail letter, a phone call and a phone call plus mailed letter
All patients will be administered an intervention that will contain one or more of 3 possible interventions (a mail letter, a phone call and a mail plus phone call). Some patients will also be assigned into a condition where none of the interventions will be present.
Patients at Black Creek CHC will only be offered a phone or a phone plus incentive intervention or a no intervention.
Control
No intervention will be offered to patients in this arm.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
a mail letter, a phone call and a phone call plus mailed letter
All patients will be administered an intervention that will contain one or more of 3 possible interventions (a mail letter, a phone call and a mail plus phone call). Some patients will also be assigned into a condition where none of the interventions will be present.
Patients at Black Creek CHC will only be offered a phone or a phone plus incentive intervention or a no intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Diabetes Action Canada
UNKNOWN
Women's College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael H Brent, MD, FRCSC
Role: PRINCIPAL_INVESTIGATOR
University Health Network, Toronto Western Hospital
Onil Bhattacharyya, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Women's College Hospital
Laura Desveaux, PhD
Role: PRINCIPAL_INVESTIGATOR
Women's College Hospital
Vess Stamenova, PhD
Role: PRINCIPAL_INVESTIGATOR
Women's College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Black Creek Community Health Centre
Toronto, Ontario, Canada
Women's College Hospital Family Health Team
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Stamenova V, Nguyen M, Onabajo N, Merritt R, Sutakovic O, Mossman K, Wong I, Ives-Baine L, Bhatia RS, Brent MH, Bhattacharyya O. Mailed Letter Versus Phone Call to Increase Diabetic-Related Retinopathy Screening Engagement by Patients in a Team-Based Primary Care Practice: Prospective, Single-Masked, Randomized Trial. J Med Internet Res. 2023 Jan 11;25:e37867. doi: 10.2196/37867.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-0068-E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.